Integra LifeSciences Net Income vs. Operating Margin
| IART Stock | USD 12.05 0.06 0.50% |
Net Loss | First Reported 1995-03-31 | Previous Quarter -484.1 M | Current Value -5.4 M | Quarterly Volatility 47.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.67 | 0.63 |
|
|
For Integra LifeSciences profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Integra LifeSciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Integra LifeSciences Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Integra LifeSciences's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Integra LifeSciences Holdings over time as well as its relative position and ranking within its peers.
Integra LifeSciences' Revenue Breakdown by Earning Segment
Check out Risk vs Return Analysis.
Integra LifeSciences Revenue Breakdown by Earning Segment
By analyzing Integra LifeSciences' earnings estimates, investors can diagnose different trends across Integra LifeSciences' analyst sentiment over time as well as compare current estimates against different timeframes.
Is there potential for Health Care Equipment & Supplies market expansion? Will Integra introduce new products? Factors like these will boost the valuation of Integra LifeSciences. Market participants price Integra higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.004 | Earnings Share (6.47) | Revenue Per Share | Quarterly Revenue Growth 0.056 | Return On Assets |
Understanding Integra LifeSciences requires distinguishing between market price and book value, where the latter reflects Integra's accounting equity. The concept of intrinsic value - what Integra LifeSciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Integra LifeSciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Integra LifeSciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Integra LifeSciences Operating Margin vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Integra LifeSciences's current stock value. Our valuation model uses many indicators to compare Integra LifeSciences value to that of its competitors to determine the firm's financial worth. Integra LifeSciences Holdings is rated second overall in net income category among its peers. It also is rated second overall in operating margin category among its peers . At this time, Integra LifeSciences' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Integra LifeSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Integra Operating Margin vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Integra LifeSciences |
| = | (6.94 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Integra LifeSciences |
| = | 0.1 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Integra Operating Margin Comparison
Integra LifeSciences is currently under evaluation in operating margin category among its peers.
Integra LifeSciences Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Integra LifeSciences, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Integra LifeSciences will eventually generate negative long term returns. The profitability progress is the general direction of Integra LifeSciences' change in net profit over the period of time. It can combine multiple indicators of Integra LifeSciences, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -24.8 M | -23.6 M | |
| Operating Income | 32.7 M | 31 M | |
| Income Before Tax | -21 M | -19.9 M | |
| Total Other Income Expense Net | -42 M | -39.9 M | |
| Net Loss | -8 M | -7.6 M | |
| Income Tax Expense | -13 M | -12.3 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M | |
| Net Loss | -8 M | -7.6 M | |
| Non Operating Income Net Other | 28.3 M | 29.7 M | |
| Interest Income | 23 M | 24.2 M | |
| Net Interest Income | -45.5 M | -47.8 M | |
| Change To Netincome | 2.5 M | 2.4 M | |
| Net Loss | (0.08) | (0.08) | |
| Income Quality | (21.43) | (20.36) | |
| Net Income Per E B T | 0.34 | 0.33 |
Integra Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Integra LifeSciences. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Integra LifeSciences position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Integra LifeSciences' important profitability drivers and their relationship over time.
Integra LifeSciences Earnings Estimation Breakdown
The calculation of Integra LifeSciences' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Integra LifeSciences is estimated to be 0.587675 with the future projection ranging from a low of 0.5675 to a high of 0.6375. Please be aware that this consensus of annual earnings estimates for Integra LifeSciences Holdings is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
0.57 Lowest | Expected EPS | 0.64 Highest |
Integra LifeSciences Earnings Projection Consensus
Suppose the current estimates of Integra LifeSciences' value are higher than the current market price of the Integra LifeSciences stock. In this case, investors may conclude that Integra LifeSciences is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Integra LifeSciences' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 11 | 85.24% | 0.0 | 0.587675 | -6.47 |
Integra LifeSciences Earnings History
Earnings estimate consensus by Integra LifeSciences analysts from Wall Street is used by the market to judge Integra LifeSciences' stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we suggest analyzing not only Integra LifeSciences' upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Integra LifeSciences Quarterly Gross Profit |
|
Integra LifeSciences Earnings per Share Projection vs Actual
Actual Earning per Share of Integra LifeSciences refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Integra LifeSciences Holdings predict the company's earnings will be in the future. The higher the earnings per share of Integra LifeSciences, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Integra LifeSciences Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Integra LifeSciences, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Integra LifeSciences should always be considered in relation to other companies to make a more educated investment decision.Integra Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Integra LifeSciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-10-30 | 2025-09-30 | 0.43 | 0.54 | 0.11 | 25 | ||
2025-07-31 | 2025-06-30 | 0.44 | 0.45 | 0.01 | 2 | ||
2025-05-05 | 2025-03-31 | 0.4311 | -0.3308 | -0.7619 | 176 | ||
2025-02-26 | 2024-12-31 | 0.8554 | 0.97 | 0.1146 | 13 | ||
2024-11-04 | 2024-09-30 | 0.39 | 0.41 | 0.02 | 5 | ||
2024-07-29 | 2024-06-30 | 0.62 | 0.63 | 0.01 | 1 | ||
2024-05-06 | 2024-03-31 | 0.55 | 0.55 | 0.0 | 0 | ||
2024-02-28 | 2023-12-31 | 0.9 | 0.89 | -0.01 | 1 | ||
2023-10-25 | 2023-09-30 | 0.78 | 0.76 | -0.02 | 2 | ||
2023-07-26 | 2023-06-30 | 0.57 | 0.71 | 0.14 | 24 | ||
2023-04-26 | 2023-03-31 | 0.74 | 0.74 | 0.0 | 0 | ||
2023-02-22 | 2022-12-31 | 0.9 | 0.94 | 0.04 | 4 | ||
2022-10-26 | 2022-09-30 | 0.72 | 0.86 | 0.14 | 19 | ||
2022-07-27 | 2022-06-30 | 0.8 | 0.81 | 0.01 | 1 | ||
2022-04-27 | 2022-03-31 | 0.68 | 0.74 | 0.06 | 8 | ||
2022-02-23 | 2021-12-31 | 0.83 | 0.84 | 0.01 | 1 | ||
2021-11-02 | 2021-09-30 | 0.72 | 0.86 | 0.14 | 19 | ||
2021-07-28 | 2021-06-30 | 0.66 | 0.79 | 0.13 | 19 | ||
2021-04-28 | 2021-03-31 | 0.57 | 0.69 | 0.12 | 21 | ||
2021-02-18 | 2020-12-31 | 0.73 | 0.84 | 0.11 | 15 | ||
2020-10-28 | 2020-09-30 | 0.54 | 0.8 | 0.26 | 48 | ||
2020-08-10 | 2020-06-30 | 0.1 | 0.33 | 0.23 | 230 | ||
2020-05-07 | 2020-03-31 | 0.63 | 0.48 | -0.15 | 23 | ||
2020-02-19 | 2019-12-31 | 0.67 | 0.68 | 0.01 | 1 | ||
2019-10-24 | 2019-09-30 | 0.65 | 0.68 | 0.03 | 4 | ||
2019-07-24 | 2019-06-30 | 0.66 | 0.73 | 0.07 | 10 | ||
2019-04-24 | 2019-03-31 | 0.61 | 0.65 | 0.04 | 6 | ||
2019-02-21 | 2018-12-31 | 0.62 | 0.65 | 0.03 | 4 | ||
2018-10-31 | 2018-09-30 | 0.59 | 0.59 | 0.0 | 0 | ||
2018-07-25 | 2018-06-30 | 0.6 | 0.6 | 0.0 | 0 | ||
2018-04-25 | 2018-03-31 | 0.49 | 0.58 | 0.09 | 18 | ||
2018-02-27 | 2017-12-31 | 0.56 | 0.64 | 0.08 | 14 | ||
2017-10-26 | 2017-09-30 | 0.47 | 0.45 | -0.02 | 4 | ||
2017-07-26 | 2017-06-30 | 0.45 | 0.45 | 0.0 | 0 | ||
2017-04-26 | 2017-03-31 | 0.38 | 0.39 | 0.01 | 2 | ||
2017-02-23 | 2016-12-31 | 0.52 | 0.52 | 0.0 | 0 | ||
2016-10-27 | 2016-09-30 | 0.44 | 0.47 | 0.03 | 6 | ||
2016-07-28 | 2016-06-30 | 0.38 | 0.4 | 0.02 | 5 | ||
2016-04-27 | 2016-03-31 | 0.37 | 0.37 | 0.0 | 0 | ||
2016-02-25 | 2015-12-31 | 0.43 | 0.44 | 0.01 | 2 | ||
2015-11-03 | 2015-09-30 | 0.37 | 0.38 | 0.01 | 2 | ||
2015-07-30 | 2015-06-30 | 0.36 | 0.4 | 0.04 | 11 | ||
2015-04-30 | 2015-03-31 | 0.32 | 0.38 | 0.06 | 18 | ||
2015-02-24 | 2014-12-31 | 0.44 | 0.47 | 0.03 | 6 | ||
2014-11-03 | 2014-09-30 | 0.37 | 0.38 | 0.01 | 2 | ||
2014-08-05 | 2014-06-30 | 0.32 | 0.34 | 0.02 | 6 | ||
2014-05-01 | 2014-03-31 | 0.29 | 0.28 | -0.01 | 3 | ||
2014-02-25 | 2013-12-31 | 0.4 | 0.39 | -0.01 | 2 | ||
2013-10-28 | 2013-09-30 | 0.35 | 0.36 | 0.01 | 2 | ||
2013-08-01 | 2013-06-30 | 0.27 | 0.3 | 0.03 | 11 | ||
2013-05-02 | 2013-03-31 | 0.23 | 0.2 | -0.03 | 13 | ||
2013-02-21 | 2012-12-31 | 0.39 | 0.39 | 0.0 | 0 | ||
2012-10-24 | 2012-09-30 | 0.38 | 0.43 | 0.05 | 13 | ||
2012-07-26 | 2012-06-30 | 0.34 | 0.37 | 0.03 | 8 | ||
2012-04-25 | 2012-03-31 | 0.3 | 0.36 | 0.06 | 20 | ||
2012-02-23 | 2011-12-31 | 0.32 | 0.36 | 0.04 | 12 | ||
2011-10-31 | 2011-09-30 | 0.38 | 0.39 | 0.01 | 2 | ||
2011-07-28 | 2011-06-30 | 0.34 | 0.35 | 0.01 | 2 | ||
2011-04-28 | 2011-03-31 | 0.33 | 0.33 | 0.0 | 0 | ||
2011-02-24 | 2010-12-31 | 0.37 | 0.4 | 0.03 | 8 | ||
2010-10-28 | 2010-09-30 | 0.33 | 0.37 | 0.04 | 12 | ||
2010-07-29 | 2010-06-30 | 0.32 | 0.34 | 0.02 | 6 | ||
2010-05-03 | 2010-03-31 | 0.28 | 0.32 | 0.04 | 14 | ||
2010-03-01 | 2009-12-31 | 0.29 | 0.3 | 0.01 | 3 | ||
2009-11-04 | 2009-09-30 | 0.26 | 0.27 | 0.01 | 3 | ||
2009-08-06 | 2009-06-30 | 0.24 | 0.26 | 0.02 | 8 | ||
2009-05-06 | 2009-03-31 | 0.23 | 0.24 | 0.01 | 4 | ||
2009-03-02 | 2008-12-31 | 0.28 | 0.27 | -0.01 | 3 | ||
2008-11-07 | 2008-09-30 | 0.23 | 0.23 | 0.0 | 0 | ||
2008-08-11 | 2008-06-30 | 0.23 | 0.25 | 0.02 | 8 | ||
2008-06-04 | 2008-03-31 | 0.2 | 0.25 | 0.05 | 25 | ||
2007-11-09 | 2007-09-30 | 0.22 | 0.2 | -0.02 | 9 | ||
2007-08-07 | 2007-06-30 | 0.18 | 0.21 | 0.03 | 16 | ||
2007-05-09 | 2007-03-31 | 0.17 | 0.17 | 0.0 | 0 | ||
2007-02-28 | 2006-12-31 | 0.21 | 0.21 | 0.0 | 0 | ||
2006-11-02 | 2006-09-30 | 0.17 | 0.18 | 0.01 | 5 | ||
2006-08-02 | 2006-06-30 | 0.16 | 0.17 | 0.01 | 6 | ||
2006-05-08 | 2006-03-31 | 0.14 | 0.16 | 0.02 | 14 | ||
2006-03-05 | 2005-12-31 | 0.19 | 0.19 | 0.0 | 0 | ||
2005-10-30 | 2005-09-30 | 0.17 | 0.18 | 0.01 | 5 | ||
2005-08-07 | 2005-06-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2005-05-08 | 2005-03-31 | 0.15 | 0.14 | -0.01 | 6 | ||
2005-03-13 | 2004-12-31 | 0.14 | 0.15 | 0.01 | 7 | ||
2004-11-07 | 2004-09-30 | 0.14 | 0.14 | 0.0 | 0 | ||
2004-07-27 | 2004-06-30 | 0.13 | 0.12 | -0.01 | 7 | ||
2004-04-27 | 2004-03-31 | 0.12 | 0.12 | 0.0 | 0 | ||
2004-02-27 | 2003-12-31 | 0.15 | 0.15 | 0.0 | 0 | ||
2003-10-31 | 2003-09-30 | 0.09 | 0.12 | 0.03 | 33 | ||
2003-07-31 | 2003-06-30 | 0.09 | 0.09 | 0.0 | 0 | ||
2003-04-25 | 2003-03-31 | 0.08 | 0.09 | 0.01 | 12 | ||
2003-02-27 | 2002-12-31 | 0.08 | 0.08 | 0.0 | 0 | ||
2002-11-04 | 2002-09-30 | 0.07 | 0.07 | 0.0 | 0 | ||
2002-08-01 | 2002-06-30 | 0.06 | 0.07 | 0.01 | 16 | ||
2002-05-08 | 2002-03-31 | 0.06 | 0.07 | 0.01 | 16 | ||
2002-02-27 | 2001-12-31 | 0.05 | 0.06 | 0.01 | 20 | ||
2001-11-07 | 2001-09-30 | 0.04 | 0.07 | 0.03 | 75 | ||
2001-08-02 | 2001-06-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2001-05-09 | 2001-03-31 | 0.03 | 0.04 | 0.01 | 33 | ||
2001-02-28 | 2000-12-31 | 0.01 | 0.03 | 0.02 | 200 | ||
2000-11-08 | 2000-09-30 | -0.01 | 0.02 | 0.03 | 300 | ||
2000-08-10 | 2000-06-30 | -0.07 | -0.02 | 0.05 | 71 | ||
2000-05-05 | 2000-03-31 | -0.05 | -0.03 | 0.02 | 40 | ||
2000-03-02 | 1999-12-31 | -0.05 | -0.02 | 0.03 | 60 | ||
1999-11-09 | 1999-09-30 | -0.08 | -0.06 | 0.02 | 25 | ||
1999-08-05 | 1999-06-30 | -0.15 | -0.08 | 0.07 | 46 | ||
1999-05-14 | 1999-03-31 | -0.07 | -0.1 | -0.03 | 42 | ||
1999-03-03 | 1998-12-31 | -0.09 | -0.08 | 0.01 | 11 | ||
1998-11-13 | 1998-09-30 | -0.1 | -0.09 | 0.01 | 10 | ||
1998-08-05 | 1998-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
1998-05-06 | 1998-03-31 | -0.1 | -0.1 | 0.0 | 0 | ||
1998-03-03 | 1997-12-31 | -0.1 | -0.12 | -0.02 | 20 | ||
1997-11-13 | 1997-09-30 | -0.07 | -0.08 | -0.01 | 14 | ||
1997-08-05 | 1997-06-30 | -0.05 | -0.07 | -0.02 | 40 | ||
1997-05-05 | 1997-03-31 | -0.07 | -0.06 | 0.01 | 14 | ||
1997-03-03 | 1996-12-31 | -0.02 | -0.08 | -0.06 | 300 | ||
1996-11-04 | 1996-09-30 | -0.04 | -0.07 | -0.03 | 75 | ||
1996-05-01 | 1996-03-31 | -0.08 | -0.06 | 0.02 | 25 | ||
1996-03-06 | 1995-12-31 | -0.07 | -0.09 | -0.02 | 28 |
Use Integra LifeSciences in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Integra LifeSciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integra LifeSciences will appreciate offsetting losses from the drop in the long position's value.Integra LifeSciences Pair Trading
Integra LifeSciences Holdings Pair Trading Analysis
The ability to find closely correlated positions to Integra LifeSciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Integra LifeSciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Integra LifeSciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Integra LifeSciences Holdings to buy it.
The correlation of Integra LifeSciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Integra LifeSciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Integra LifeSciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Integra LifeSciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Integra LifeSciences position
In addition to having Integra LifeSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sport Products Thematic Idea Now
Sport Products
Companies manufacturing sporting goods and accessories. The Sport Products theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sport Products Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.